Disordered mineral metabolism is not a risk factor for loss of residual renal function in dialysis patients

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1580-1587

  Noordzij, Marlies ^a   Voormolen, Nora M C ^b   Boeschoten, Elisabeth W ^c   Dekker, Friedo W ^b   Bos, Willem J ^d   Krediet, Raymond T ^a   Korevaar, Johanna C ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Hans Mak Institute   (Netherlands)

^d ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Dialysis; Mineral metabolism; Phosphorus; Residual renal function

Indexed keywords

CALCIUM; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; AGED; ANURIA; ARTICLE; CALCIUM BLOOD LEVEL; CALCULATION; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; MINERAL METABOLISM; NETHERLANDS; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; RESIDUAL RENAL FUNCTION; RISK FACTOR;

AGED; CALCIUM; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; METABOLIC DISEASES; MIDDLE AGED; MINERALS; NETHERLANDS; PERITONEAL DIALYSIS; PHOSPHORUS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RENAL DIALYSIS; RISK FACTORS;

EID: 65249160534     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn768     Document Type: Article

References (29)

1. Merkus MP, Jager KJ, Dekker FW et al. Predictors of poor outcome in chronic dialysis patients: The Netherlands Cooperative Study on the Adequacy of Dialysis. Am J Kidney Dis 2000; 35: 69-79
2. Termorshuizen F, Dekker FW, van Manen JG et al. Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of The Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 2004; 5: 1061-1070
3. Shemin D, Bostom AG, Laliberty P et al. Residual renal function and mortality risk in hemodialysis patients. Am J Kidney Dis 2001; 38: 85-90
4. Wang AY, Woo J, Wang M et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20: 396-403
5. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12: 2158-2162
6. Noordzij M, Korevaar JC, Boeschoten EW et al. The K/DOQI guideline for bone metabolism and disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 2005; 46: 925-932
7. Ritz E, Gross ML, Dikow R. Role of calcium-phosphorous disorders in the progression of renal failure. Kidney Int 2005; 68(Suppl 99): S66-S70
8. Wang AY, Woo J, Sea MM et al. Hyperphosphatemia in Chinese peritoneal dialysis patients with and without residual kidney function: what are the implications? Am J Kidney Dis 2004; 43: 712-720
9. Neves KR, Graciolli FG, dos Reis LM et al. Adverse effects of hyper-phosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. Kidney Int 2004; 66: 2237-2244
10. Barsotti G, Giannoni A, Morelli E et al. The decline of renal function slowed by very low phosphorus intake in chronic renal patients following a low nitrogen diet. Clin Nephrol 1984; 21: 54-59
11. Kasiske BL, Lakatua JD, Ma JZ et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. Am J Kidney Dis 1998; 31: 954-961
12. Voormolen N, Noordzij M, Grootendorst DC et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916
13. Schwarz S, Trivedi BK, Kalantar-Zadeh K et al. Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 825-831
14. Norris KC, Greene T, Kopple J et al. Baseline predictors of renal disease progression in the African American study of hypertension and kidney disease. J Am Soc Nephrol 2006; 17: 2928-2936
15. Korevaar JC, Boeschoten EW, Dekker FW et al. What have we learned from NECOSAD? Practical implications for peritoneal dialysis patients. Perit Dial Int 2007; 27: 11-15
16. van Dijk PC, Jager KJ, de Charro F et al. Renal replacement therapy in Europe: the resultsof acollaborative effortby the ERA-EDTA registry and six national or regional registries. Nephrol Dial Transplant 2001; 16: 1120-1129
17. Davies SJ, Russell L, Bryan J et al. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26: 353-361
18. Visser R, Dekker FW, Boeschoten EW et al. Reliability of the 7-point subjective global assessment scale in assessing nutritional status of dialysis patients. Adv Perit Dial 1999; 15: 222-225
19. Watson PE, Watson ID, Batt RD. Total body water volumes for adult males and females estimated from simple anthropometric measurements. Am J Clin Nutr 1980; 33: 27-39
20. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993; 4: 1205-1213
21. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42(Suppl 3): S1-S202
22. Portale AA. Blood calcium, phosphorus, and magnesium, In: Favus MJ (ed.). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 4th edn. Philadelphia: Lippincott Williams & Wilkins, 1999, 115-118
23. Moist LM, Port FK, Orzol SM et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-564
24. Agarwal R, Muralidhar A, Tian J et al. Antiproteinuric effect of oral paracalcitol in chronic kidney disease. Kidney Int 2005; 68: 2823- 2828
25. Tian J, Liu Y, Williams LA et al. Potential role of active vitamin D in retarding the progression of chronic kidney disease. Nephrol Dial Transplant 2007; 22: 321-328
26. Fliser D, Kollerits B, Neyer U et al. Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) study. J Am Soc Nephrol 2007; 18: 2600-2608
27. Koizumi T, Murakami K, Nakayama H et al. Role of dietary phosphorus in the progression of renal failure. Biochem Biophys Res Commun 2002; 295: 917-921
28. Cozzolino M, Dusso AS, Liapis H et al. The effects of sevelamer hydrochloride and calcium carbonateonkidney calcificationinuremic rats. J Am Soc Nephrol 2002; 13: 2299-2308
29. Jansen MA, Hart AA, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046-1053